Jacobs Levy Equity Management’s Organogenesis Holdings ORGO Stock Holding History

Jacobs Levy Equity Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Buy	+692,197	New	+$1.69M	0.01%	634
2025 Q2	–	Sell	-47,516	Closed	-$205K	–	1130
2025 Q1	$205K	Sell	47,516 -1,097	-2%	-$4.43K	﹤0.01%	1027
2024 Q4	$156K	Sell	48,613 -232,865	-83%	-$781K	﹤0.01%	908
2024 Q3	$805K	Sell	281,478 -148,326	-35%	-$416K	﹤0.01%	767
2024 Q2	$1.2M	Buy	429,804 +243,568	+131%	+$654K	0.01%	692
2024 Q1	$529K	Buy	186,236 +144,771	+349%	+$492K	﹤0.01%	813
2023 Q4	$170K	Buy	+41,465	New	+$116K	﹤0.01%	936
2023 Q2	–	Sell	-867,261	Closed	-$1.85M	–	1050
2023 Q1	$1.85M	Buy	+867,261	New	+$2.14M	0.01%	588

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jacobs Levy Equity Management's ORGO Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 692,197 shares worth $1.68M. The stake represents 0.01% of the portfolio and ranks #634 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in ORGO as recently as Q1 2025.

Jacobs Levy Equity Management first reported a position in ORGO in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.85M in Q1 2023. 135 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Jacobs Levy Equity Management held 692,197 shares of Organogenesis Holdings worth $1.68M as of Q2 2026.
Organogenesis Holdings was a new Jacobs Levy Equity Management position in Q2 2026.
Organogenesis Holdings made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #634 holding.
Jacobs Levy Equity Management first reported a position in Organogenesis Holdings in Q1 2023 and has held it in 8 quarters since.
Jacobs Levy Equity Management's Organogenesis Holdings position peaked at $1.85M in Q1 2023.
135 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.